Product NDC: | 59702-800 |
Proprietary Name: | Atuss DS Tannate Suspension |
Non Proprietary Name: | Tannate Suspension |
Active Ingredient(s): | 4; 30; 30 mg/5mL; mg/5mL; mg/5mL & nbsp; Tannate Suspension |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59702-800 |
Labeler Name: | Atley Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20061121 |
Package NDC: | 59702-800-15 |
Package Description: | 15 mL in 1 BOTTLE (59702-800-15) |
NDC Code | 59702-800-15 |
Proprietary Name | Atuss DS Tannate Suspension |
Package Description | 15 mL in 1 BOTTLE (59702-800-15) |
Product NDC | 59702-800 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Tannate Suspension |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20061121 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Atley Pharmaceuticals, Inc. |
Substance Name | CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
Strength Number | 4; 30; 30 |
Strength Unit | mg/5mL; mg/5mL; mg/5mL |
Pharmaceutical Classes | Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],Sigma-1 Agonist [EPC],Uncompetitive NMDA Receptor Antagonists [MoA],Sigma-1 Receptor Agonists [MoA],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |